Candel Therapeutics, Inc.
← Back to CADL Overview

Candel Therapeutics, Inc. (CADL)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-2.63

Financial Fundamentals

CADLQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2020-03-31-18.48
2020-06-30-11.39
2020-09-30-12.82
2020-12-31-3.13
2021-03-31-7.31
2021-06-30-2.54
2021-09-30-3.91
2021-12-3128.57
2022-03-31-41.77
2022-06-30-5.62
2022-09-30-2.61
2022-12-31-2.54
2023-03-31-1.11
2023-06-30-0.95
2023-09-30-0.79
2023-12-31-0.96
2024-03-31-1.55
2024-06-30-2.12
2024-09-30-5.21
2024-12-31-5.48
2025-03-316.06
2025-06-30-13.58
2025-09-30-6.21
2025-12-31-2.63

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.